Washburn Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,830
| Closed | -$224K | – | 46 |
|
2023
Q3 | $224K | Sell |
1,830
-100
| -5% | -$12.2K | 0.19% | 43 |
|
2023
Q2 | $245K | Sell |
1,930
-575
| -23% | -$73K | 0.2% | 41 |
|
2023
Q1 | $324K | Sell |
2,505
-200
| -7% | -$25.8K | 0.28% | 44 |
|
2022
Q4 | $355K | Sell |
2,705
-525
| -16% | -$68.9K | 0.32% | 41 |
|
2022
Q3 | $378K | Hold |
3,230
| – | – | 0.36% | 38 |
|
2022
Q2 | $380K | Buy |
3,230
+1,235
| +62% | +$145K | 0.33% | 43 |
|
2022
Q1 | $260K | Sell |
1,995
-4
| -0.2% | -$521 | 0.17% | 57 |
|
2021
Q4 | $305K | Buy |
1,999
+314
| +19% | +$47.9K | 0.18% | 44 |
|
2021
Q3 | $272K | Buy |
+1,685
| New | +$272K | 0.18% | 50 |
|